Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Gabexate Mesylate for Injection

Approval Number

国药准字H20084323

Company山西阳和医药技术有限公司

Registration Date

December 7, 2022

Previous Approval Numbers

国药准字H20084323

Drug Information

Generic Name

注射用甲磺酸加贝酯

Dosage Form

注射剂

Strength

0.1g

Drug Type

化学药品

Registration Date

December 7, 2022

Company Information

Applicant Company

Company Name山西阳和医药技术有限公司

Company Address

山西省大同市阳高县西北街6号B

Manufacturing Company

Company Name陕西博森生物制药股份集团有限公司

Company Address

陕西省西安市高新区新型工业园创新路7号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy